David A. Siegel Amicus Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q4 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 111,976 shares of FOLD stock, worth $954,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111,976

Previous 59,976 86.7%

Holding current value

$954,035

Previous $640,000 64.69%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$9.36 - $12.01 $486,719 - $624,520	52,000 Added 86.7%	111,976 $1.05 Million
Q3 2024 Nov 14, 2024	SELL	$9.55 - $12.09 $226,335 - $286,533	-23,700 Reduced 28.32%	59,976 $640,000
Q2 2024 Aug 14, 2024	BUY	$9.04 - $11.75 $534,264 - $694,425	59,100 Added 240.48%	83,676 $830,000
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $280,903 - $349,962	24,576 New	24,576 $289,000
Q2 2023 Aug 14, 2023	SELL	$10.72 - $13.3 $2.15 Million - $2.67 Million	-201,000 Reduced 46.03%	235,676 $2.96 Million
Q1 2023 May 15, 2023	SELL	$10.91 - $13.54 $896,802 - $1.11 Million	-82,200 Reduced 15.84%	436,676 $4.84 Million
Q4 2022 Feb 14, 2023	SELL	$9.89 - $12.7 $2.07 Million - $2.66 Million	-209,500 Reduced 28.76%	518,876 $6.34 Million
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $1.1 Million - $1.43 Million	112,000 Added 18.17%	728,376 $7.6 Million
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $94,696 - $169,024	-15,200 Reduced 2.41%	616,376 $6.62 Million
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $1.77 Million - $2.8 Million	-224,000 Reduced 26.18%	631,576 $5.98 Million
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $4.94 Million - $6.26 Million	503,500 Added 143.01%	855,576 $9.88 Million
Q3 2021 Nov 15, 2021	SELL	$8.74 - $11.84 $5.76 Million - $7.81 Million	-659,400 Reduced 65.19%	352,076 $3.36 Million
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $4.72 Million - $5.81 Million	-542,300 Reduced 34.9%	1,011,476 $9.75 Million
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $4.67 Million - $12.1 Million	507,600 Added 48.52%	1,553,776 $15.4 Million
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $9.27 Million - $17.1 Million	688,200 Added 192.25%	1,046,176 $24.2 Million
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $2.76 Million - $3.4 Million	214,100 Added 148.81%	357,976 $5.06 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $1.09 Million - $1.93 Million	122,976 Added 588.4%	143,876 $2.17 Million
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $202,055 - $340,112	-30,476 Reduced 59.32%	20,900 $193,000
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $384,292 - $552,292	51,376 New	51,376 $500,000
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $210,080 - $273,440	-16,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$13.76 - $17.12 $16,512 - $20,544	-1,200 Reduced 6.98%	16,000 $241,000
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $22,518 - $29,231	1,800 Added 11.69%	17,200 $248,000
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $180,796 - $243,012	15,400	15,400 $232,000

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

283M

Call Options Held

467K

Put Options Held

515K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.39B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account